Arranta Bio Holdings, LLC – Trademark Portfolio
Entity Type: 16
Arranta Bio Holdings, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ARRANTABIO, ARRANTA BIO, MARVELOUS MICROBIOME, ALIVE BIOTHERAPEUTIC PRODUCTS, and ACTALIVE BIOTHERAPEUTIC PRODUCTS. The owner is based in Watertown, MA.
650 Pleasant Street
Watertown, MA 02472
Showing of trademarks Trademarks
Trademark Classifications
Arranta Bio Holdings, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Arranta Bio Holdings, LLC have?
Arranta Bio Holdings, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 7 registered.
What trademark classes does Arranta Bio Holdings, LLC file in?
Arranta Bio Holdings, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Arranta Bio Holdings, LLC's most well-known trademarks?
Arranta Bio Holdings, LLC's registered trademark portfolio includes well-known marks such as ARRANTABIO, ARRANTA BIO, MARVELOUS MICROBIOME, ALIVE BIOTHERAPEUTIC PRODUCTS, and ACTALIVE BIOTHERAPEUTIC PRODUCTS. These are among 7 currently registered trademarks in the portfolio.
What is Arranta Bio Holdings, LLC's trademark registration success rate?
Arranta Bio Holdings, LLC has a 100% trademark registration rate, with 7 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.